144 related articles for article (PubMed ID: 28634616)
1. Lineage switch from B acute lymphoblastic leukemia to acute monocytic leukemia with persistent t(4;11)(q21;q23) and cytogenetic evolution under CD19-targeted therapy.
Balducci E; Nivaggioni V; Boudjarane J; Bouriche L; Rahal I; Bernot D; Alazard E; Duployez N; Grardel N; Arnoux I; Lafage-Pochitaloff M; Michel G; Nadel B; Loosveld M
Ann Hematol; 2017 Sep; 96(9):1579-1581. PubMed ID: 28634616
[No Abstract] [Full Text] [Related]
2. [A case of t(4;11) congenital leukemia that transformed from pre B lymphoid to monocytic morphology].
Shibuya A; Danya N; Shinozawa T; Katayama I; Shinohara T
Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):872-8. PubMed ID: 3206985
[No Abstract] [Full Text] [Related]
3. Concepts in immuno-oncology: tackling B cell malignancies with CD19-directed bispecific T cell engager therapies.
Viardot A; Locatelli F; Stieglmaier J; Zaman F; Jabbour E
Ann Hematol; 2020 Oct; 99(10):2215-2229. PubMed ID: 32856140
[TBL] [Abstract][Full Text] [Related]
4. Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis.
Haddox CL; Mangaonkar AA; Chen D; Shi M; He R; Oliveira JL; Litzow MR; Al-Kali A; Hogan WJ; Elliott MA
Blood Cancer J; 2017 Sep; 7(9):e607. PubMed ID: 29016570
[No Abstract] [Full Text] [Related]
5. Infant acute lymphoblastic leukemia with t(11;16)(q23;p13.3) and lineage switch into acute monoblastic leukemia.
Stasik C; Ganguly S; Cunningham MT; Hagemeister S; Persons DL
Cancer Genet Cytogenet; 2006 Jul; 168(2):146-9. PubMed ID: 16843104
[TBL] [Abstract][Full Text] [Related]
6. Translocation t(11;22)(q23;q11) in an adult with acute monoblastic leukemia.
Kobayashi H; Miyachi H; Ogawa T; Jimbo M
Jpn J Med; 1990; 29(5):527-32. PubMed ID: 2089178
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia.
Ribera JM
Expert Rev Hematol; 2017 Dec; 10(12):1057-1067. PubMed ID: 29082835
[TBL] [Abstract][Full Text] [Related]
8. Acute monocytic leukemia with translocation t(1;11) (p31;q23): simultaneous staining of chromosomes and cell surface antigens.
Nölle I; Schlegelberger B; Schmitz N; Bödewadt-Radzun S; Grote W
Haematol Blood Transfus; 1990; 33():145-9. PubMed ID: 1691129
[TBL] [Abstract][Full Text] [Related]
9. Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomab.
El Chaer F; Ali OM; Sausville EA; Law JY; Lee ST; Duong VH; Baer MR; Koka R; Singh ZN; Wong J; Yared JA; Griffiths EA; Emadi A
Am J Hematol; 2019 Jan; 94(1):E7-E8. PubMed ID: 30328137
[No Abstract] [Full Text] [Related]
10. Two consecutive immunophenotypic switches in a child with MLL-rearranged acute lymphoblastic leukemia.
Germano G; Pigazzi M; del Giudice L; Campo Dell'Orto M; Spinelli M; Zangrando A; Paolucci P; Ladogana S; Basso G
Haematologica; 2006 May; 91(5 Suppl):ECR09. PubMed ID: 16709517
[TBL] [Abstract][Full Text] [Related]
11. A complex translocation, t(4;11;13)(q21;q23;q12-14), in a case of infantile acute lymphoblastic leukemia.
Matsunaga AT; Torfi H; Feusner J
Cancer Genet Cytogenet; 1993 Sep; 69(2):153-5. PubMed ID: 8402556
[TBL] [Abstract][Full Text] [Related]
12. Monitoring minimal/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy.
Liu Z; Li Y; Shi C
Int J Hematol; 2021 Mar; 113(3):337-343. PubMed ID: 33502735
[TBL] [Abstract][Full Text] [Related]
13. Strong expansion of normal CD19-negative B-cell precursors after the use of blinatumomab in the first-line therapy of acute lymphoblastic leukaemia in children.
Mikhailova E; Roumiantseva J; Illarionova O; Lagoyko S; Miakova N; Zerkalenkova E; Zharikova L; Olshanskaya Y; Novichkova G; Maschan M; Henze G; Karachunskiy A; Popov A
Br J Haematol; 2022 Jan; 196(1):e6-e9. PubMed ID: 34346071
[No Abstract] [Full Text] [Related]
14. A lineage switch from AML to ALL with persistent translocation t(4;11) in congenital leukemia.
Krawczuk-Rybak M; Zak J; Jaworowska B
Med Pediatr Oncol; 2003 Jul; 41(1):95-6. PubMed ID: 12764763
[No Abstract] [Full Text] [Related]
15. Immunophenotypic, cytogenetic and molecular investigations in two cases of CALLA positive acute myeloid leukemia.
Fagioli F; Lanza F; Carli MG; Cuneo A; Gandini D; Del Senno L; Castoldi G
Haematologica; 1990; 75(5):407-11. PubMed ID: 2097259
[TBL] [Abstract][Full Text] [Related]
16. Pre-B acute lymphoblastic leukemia in a 3-year-old boy with pre-acute myelogenous leukemia myelodysplastic syndrome: cytogenetic evidence of common early progenitor cell ontogeny.
Rossbach HC; Sutcliffe MJ; Chamizo W; Haag MM; Grana NH; Washington KR; Barbosa JL
J Pediatr Hematol Oncol; 1998; 20(4):347-52. PubMed ID: 9703011
[TBL] [Abstract][Full Text] [Related]
17. Translocation (2;9)(p12;p23) in a case of acute leukemia with t(4;11)(q21;q23). Lack of rearrangement of the kappa and interferon gene loci.
Paietta E; Van Ness B; Le Beau MM; Bennett J; Cassileth P; Wiernik PH
Cancer Genet Cytogenet; 1992 May; 60(1):82-5. PubMed ID: 1375531
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of blinatumomab: a real world data.
Apel A; Ofran Y; Wolach O; Shimony S; Ram R; Levi I; Zektser M; Koren-Michowitz M
Ann Hematol; 2020 Apr; 99(4):835-838. PubMed ID: 32076826
[TBL] [Abstract][Full Text] [Related]
19. Translocation of CD3D gene in an acute myeloid leukemia (M5) with t(11;17)(q23;21).
Pereira MS; Silva ML; Valente AN; de Souza MH; Abdelhay E
Cancer Genet Cytogenet; 1993 Dec; 71(2):173-5. PubMed ID: 8281523
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.
Topp MS; Kufer P; Gökbuget N; Goebeler M; Klinger M; Neumann S; Horst HA; Raff T; Viardot A; Schmid M; Stelljes M; Schaich M; Degenhard E; Köhne-Volland R; Brüggemann M; Ottmann O; Pfeifer H; Burmeister T; Nagorsen D; Schmidt M; Lutterbuese R; Reinhardt C; Baeuerle PA; Kneba M; Einsele H; Riethmüller G; Hoelzer D; Zugmaier G; Bargou RC
J Clin Oncol; 2011 Jun; 29(18):2493-8. PubMed ID: 21576633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
